Clinical Trial Update: An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition [NA]

View source ↗

Summary

An open-label clinical trial assesses whether the probiotic Lacticaseibacillus paracasei PS23 can improve cognition in individuals with Subjective Cognitive Dec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subjective Cognitive Decline

Drugs mentioned

• Lacticaseibacillus paracasei PS23 (Lacticaseibacillus paracasei PS23)

Snippet

Sponsor: Chi-Chang Huang | Conditions: Subjective Cognitive Decline (SCD) | NA | Status: ENROLLING_BY_INVITATION